Drug
Vorasidenib
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hepatic Cytolysis | 34 | 110.4 | 117.9 | signal |
| 2 | Gamma-glutamyltransferase Increased | 28 | 50.0 | 52.7 | signal |
| 3 | Alanine Aminotransferase Increased | 76 | 49.0 | 57.0 | signal |
| 4 | Aspartate Aminotransferase Increased | 61 | 45.5 | 51.3 | signal |
| 5 | Liver Function Test Increased | 18 | 33.4 | 34.6 | signal |
| 6 | Hepatotoxicity | 18 | 32.2 | 33.2 | signal |
| 7 | Brain Oedema | 9 | 28.2 | 28.7 | signal |
| 8 | Drug-induced Liver Injury | 17 | 21.8 | 22.5 | signal |
| 9 | Malignant Neoplasm Progression | 41 | 15.9 | 17.2 | signal |